Consistent with that prediction, reduced NIAM expression in mice yielded a tumor phenotype characterized by the development of both benign and cancerous lesions, including early B-cell lymphoma. This evidence concerns the gene TBRG1 and B-cell non-Hodgkin lymphoma.